Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Candace Holloway

Nurse Practitioner, Family Canton, MS Nurse Practitioner

NPI 1801479720 CMS profile 11066954

1668 West Peace Street, Canton, MS 39046

Open in the dashboard

General payments

$3,972

15 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Candace Holloway of Canton, MS is reported in the CMS Open Payments database as having received $3,972 across 15 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,863 8
2024 General $20 1
2023 General $50 3
2022 General $39 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Candace Holloway
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Candace Holloway were reported at $3,863. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Candace Holloway Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $0 $124 $35–$379 $132
2022 $39 $141 $44–$430 $149
2023 $50 $154 $49–$476 $160
2024 $20 $165 $51–$504 $164
2025 $3,863 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Midmark Corporation $3,786 4 payments
  2. Gilead Sciences, Inc. $86 5 payments
  3. Averitas Pharma Inc. $49 2 payments
  4. Merck Sharp & Dohme Corporation $16 1 payment
  5. Lilly USA, LLC $15 1 payment
  6. GlaxoSmithKline, LLC. $15 1 payment
  7. Organon LLC $5 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $3,574 2 payments
  2. Food and Beverage $398 13 payments
Products named General payments · program years 2022–2025
  1. Qutenza $49 2 payments
  2. PIFELTRO $16 1 payment
  3. Epclusa $16 1 payment
  4. MOUNJARO $15 1 payment
  5. ZEPBOUND $15 1 payment
  6. BEXSERO $15 1 payment
  7. PEDIARIX $15 1 payment
  8. NEXPLANON $5 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 63 drugs

Part D claims

2,015

Median for Nurse Practitioner: 389

Drug cost

$92,912

Median for Nurse Practitioner: $21,885

Branded share of claims

20.6%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 26 $28,731
Eliquis Apixaban Brand 24 $13,392
Farxiga Dapagliflozin Propanediol Brand 17 $13,248
Ozempic Semaglutide Brand 12 $11,426
Myrbetriq Mirabegron Brand 18 $8,576
Lantus Solostar Insulin Glargine,hum.Rec.Anlog Brand 29 $2,485
Albuterol Sulfate Hfa Albuterol Sulfate Brand 90 $2,366
Atorvastatin Calcium Generic 163 $1,279
Zafemy Norelgestromin/Ethin.Estradiol Brand 11 $1,273
Novolog Flexpen Insulin Aspart Brand 12 $634

The 10 drugs with the highest cost, of 63 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Records

15 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record